Literature DB >> 3040052

Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM.

G Franchini, E Collalti, S K Arya, E M Fenyö, G Biberfeld, J F Zagury, P J Kanki, F Wong-Staal, R C Gallo.   

Abstract

A new primate retrovirus, STLV-IIIAGM, has been recently isolated from healthy African green monkeys and is apparently nonpathogenic in its natural host. However, spontaneous infection as well as inoculation of STLV-IIIAGM into macaques induces a disease with clinical features that resemble human AIDS. Independent isolates of human retroviruses, serologically closely related to STLV-IIIAGM, have been obtained from healthy individuals (HTLV-IV) and patients with immunodeficiency (LAV-2FG and SBL 6669) from West Africa. The latter have also been referred to as HIV-2 because, like HTLV-III/HIV-1, they may be associated with immune deficiency, or as West African human retroviruses because of their prevalence and probable origin from that region. We have molecularly cloned the STLV-IIIAGM genome and have generated probes from the gag-pol and envelope genes to analyze the genetic relatedness of these simian and human retroviruses. Our results indicate that all these retroviruses are genetically closely related to each other, HTLV-IV and STLV-IIIAGM differing only by a few restriction enzyme sites while LAV-2FG and SBL 6669 exhibit greater polymorphism from HTLV-IV/STLV-IIIAGM. These data mirror the variable degree of relatedness among members of the first subgroup of human retroviruses, HTLV-III/HIV.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040052     DOI: 10.1089/aid.1987.3.11

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.

Authors:  S D Griffin; J F Allen; A M Lever
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Expression of human immunodeficiency virus genes using baculovirus expression system.

Authors:  C Y Kang
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

3.  Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.

Authors:  J E Hansen; C Nielsen; M Arendrup; S Olofsson; L Mathiesen; J O Nielsen; H Clausen
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope.

Authors:  M L Huang; M Essex; T H Lee
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone.

Authors:  G Franchini; K A Fargnoli; F Giombini; L Jagodzinski; A De Rossi; M Bosch; G Biberfeld; E M Fenyo; J Albert; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus.

Authors:  Bianli Xu; Licheng Liu; Xueyong Huang; Hong Ma; Yuan Zhang; Yanhua Du; Pengzhi Wang; Xiaoyan Tang; Haifeng Wang; Kai Kang; Shiqiang Zhang; Guohua Zhao; Weili Wu; Yinhui Yang; Haomin Chen; Feng Mu; Weijun Chen
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

8.  A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus.

Authors:  Nobuaki Shimizu; Atsushi Tanaka; Takahisa Mori; Takahiro Ohtsuki; Aliful Hoque; Atsushi Jinno-Oue; Chatchawann Apichartpiyakul; Shigeru Kusagawa; Yutaka Takebe; Hiroo Hoshino
Journal:  Retrovirology       Date:  2008-06-25       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.